1.
The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands
Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016
The True Face of Myelodysplastic Syndromes and Related Neoplasms in the Netherlands: Studies based on population-based registries
2.
3.